A Review on Acute Respiratory Distress Syndrome in Animal Models | Chapter 3 | Innovations in Biological Science Vol. 5

 

The present study provides the various methods for insulting ARDS in animal model, along with advantage and disadvantage of each method. Acute Respiratory Distress Syndrome (ARDS) is an acute inflammatory lung injury. There is an immune-cell-mediated decline of the alveolar epithelial-interstitial-endothelial complex walls in the exudative phase, permitting plasma, plasma proteins, and cellular content into successively flood the interstitium and airspace. ARDS occurs when there is disruption in the alveolar-capillary barrier followed by the deposition of protein rich fluid inside the alveoli of the lungs. Less oxygen reaches the bloodstream as a result of this protein-rich fluid, which prevents the lungs from filling with enough air. As a result, the organs lose some of the oxygen necessary for normal operation. Aspiration of stomach contents, pneumonia, sepsis, and severe trauma are among the several clinical conditions linked to the onset of ARDS. The various clinical disorders that are associated with the development of ARDS include sepsis, pneumonia, aspiration of gastric contents, and major trauma. Human ARDS is not caused by any single event and hence here is no such existing animal model that would completely mimic Human ARDS.

 

Author(s)details:-

 

Mr. Subham Kumar Panda
Department of Toxicology, Vipragen Biosciences Private Limited, Mysuru, Karnataka, India.

 

Dr. V. G. S. Sharma
Animal Testing Laboratory, Bharat Serums and Vaccines Limited, Ambernath, Mumbai, India.

 

Prof. (Dr.) B. Ray
Department of Pharmacology, College of Pharmaceutical Sciences, Puri, Odisha, India.

 

Please See the book here :-   https://doi.org/10.9734/bpi/ibs/v5/3621G

Assessment of Mortality Risk Factors in Patients with Severe COVID-19 Acute Respiratory Distress Syndrome | Chapter 15 | New Advances in Medicine and Medical Science Vol. 6

 The aim concerning this study was to identify risk determinants predicting humanness in patients with harsh COVID-19 complicated with ARDS. We particularly tested the friendship of these clinical outcomes accompanying the changes in PaO2/FiO2 ratio (P/F), arterial blood pH the fortification to ground glass opacities percentage (C/ GGO) the Murray lung injury score (MLIS). COVID-19 affliction caused by severe severe respiratory syndrome coronavirus 2 (SARS-CoV-2), that originated in China, has made a global outbreak that has touched more than 70 million society worldwide. . The dispassionate characteristics of COVID-19 survivors and non-survivors ARDS groups were compared clinically, workshop, and radiographically.Results indicated that the median age of non-survivors ARDS sufferers was 68.4 years traditional, which was significantly earlier than those with survivors ARDS by 9,9 years. Male and subjects with BMI>30 were more inclined die from ARDS. The prevalence of fortification (Consolidation\ground glass opacities ratio>1) in alveolus, secondary bacterial contamination, mechanical ventilation and pack beneficial dexamethasone before intubation were common among non-survivors ARDS.The principles of assessing scores (MLIS, Cons/GGO percentage, P/F ratio and SOFA) were changed otherwise. Among non-survivor group these scores were getting decaying by time, and in contrary to these with survivor all these scores were recover and to the end of the 16-th were near usual ranges. Partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2) event of admission again was significantly lower compared to survivors ARDS inmates (p<0.05) and arterial blood gas reasoning values were considerably differ: partial pressure of colorless odorless gas (PaCO2) was markedly higher (p=0.023), PaO2 was lower (p=0.026) and acridness of the blood pH was likewise lower (p=0.02).We discovered risk factors for oblivion in ARDS patients with harsh COVID-19. The clinical effects of patients with harsh COVID-19 complicated by ARDS may be jolted by the healthcare providers' use of these verdicts.

Author(s) Details:

Alizamin Sadigov,
Terapeutic Education Clinic, Medical University, Baku City, Azerbaijan.

Malahat Sultanova,
Surgery Education Clinic, Medical University, Baku City, Azerbaijan.

Emil Gasimov,
New Hospital, Baku City, Azerbaijan.

Gunel Sadigova,
Terapeutic Education Clinic, Medical University, Baku City, Azerbaijan.

Sharaf Huseynova,
Healthcare Center of Baku, Baku City, Azerbaijan.

Cavid Pashayev,
Baku Medical Center, Baku City, Azerbaijan.

Please see the link here: https://stm.bookpi.org/NAMMS-V6/article/view/10996

COVID-19 Sepsis: Based on Molecular Hemostatic Mechanism| Chapter 1 | Current Overview on Disease and Health Research Vol. 7

 The pathogenetic system of macrothrombosis characterized by pulmonary thromboembolism (PTE) and deep mood throm- bosis (DVT) coinciding with ARDS in COVID-19 will be explained from the idea of the hemostatic essentials. Acute respiring distress disease (ARDS) is a symbol of COVID-19 sepsis and results from the bacterium' pulmonary tropism and the host's endothelial variety. Patients accompanying Multiorgan Dysfunction Syndrome (MODS) the one have ARDS usually have distributed vascular microthrombotic disease (VMTD). In answer to the growing infection of blood, the host activates the complement plan that produces terminal complement complex C5b-9 to counteract pathogen. C5b-9 causes pore composition on the sheath of host endothelial containers (ECs) if CD59 is underexpressed. Also, vigorous S protein allure to endothelial ACE2 receptor damages ECs. However, EA-VMTD can orchestrate more intricate dispassionate phenotypes, in the way that thrombotic thrombocytopenic purpura (TTP)-like condition, hepatic coagulopathy, MODS, and linked calculating-macrothrombotic syndrome. In COVID-19, microthrombosis originally influences the alveoli per tropism beginning ARDS. ARDS and pulmonary thromboembolism (PTE) have commonly coexisted in this place pandemic. Analysis established two hemostatic believes implies that PTE began by triggered ULVWF and TF courses is macrothrombosis and ARDS began by activated ULVWF course is EA-VMTD. The thrombotic disorder of COVID-19 infection of blood is agreeing accompanying the idea that ARDS is bug-induced distributed EA- VMTD and PTE is in-emergency room vascular harm-accompanying macrothrombosis that is not straightforwardly related to zealous pathogenesis. The pathogenesis-located healing approach is conferred for the situation of EA-VMTD accompanying antimicrothrombotic regimen and the potential need of trick- oagulation medicine for coexisting macrothrombosis in inclusive COVID-19 care.

Author(s) Details:

Jae C. Chang,
School of Medicine, University of California, Irvine, USA.

Please see the link here: https://stm.bookpi.org/CODHR-V7/article/view/9429

A Literature Review of Prone Position in Non-intubated Patients with COVID-19 as a Useful Maneuver to Avoid Mechanical Ventilation | Chapter 10 | Highlights on Medicine and Medical Research Vol. 11

 Coronavirus disease 2019 (COVID-19) has a wide variety of symptoms, from asymptomatic to acute respiratory distress syndrome (ARDS). The prone position is commonly used in ARDS patients on mechanical ventilation, and its benefits have been identified. The prone position in an awake patient differs from the prone position in a patient who is receiving intrusive mechanical ventilation. With COVID-19, this manoeuvre can be extrapolated to non-intubated patients, allowing some patients to prevent mechanical ventilation. The advantages of this action have been shown in previous studies.

Author (s) Details

Juárez-Villa Daniel
Department of Internal Medicine, Division of Medicine, Hospital de Especialidades del Centro Médico Nacional “Siglo XXI”, Instituto Mexicano del Seguro Social, México City, 06720, México.

Mora-Ruiz Pablo
Department of Internal Medicine, Division of Medicine, Hospital de Especialidades del Centro Médico Nacional “Siglo XXI”, Instituto Mexicano del Seguro Social, México City, 06720, México.

Sáenz-Luna Carlos
Department of Internal Medicine, Division of Medicine, Hospital de Especialidades del Centro Médico Nacional “Siglo XXI”, Instituto Mexicano del Seguro Social, México City, 06720, México.

Zavala-Jonguitud Luis
Department of Internal Medicine, Division of Medicine, Hospital de Especialidades del Centro Médico Nacional “Siglo XXI”, Instituto Mexicano del Seguro Social, México City, 06720, México.

Olascoaga-Lugo Arturo
Department of Internal Medicine, Division of Medicine, Hospital de Especialidades del Centro Médico Nacional “Siglo XXI”, Instituto Mexicano del Seguro Social, México City, 06720, México.

Flores Guillermo
Department of Internal Medicine, Division of Medicine, Hospital de Especialidades del Centro Médico Nacional “Siglo XXI”, Instituto Mexicano del Seguro Social, México City, 06720, México.

Zepeda-Quiroz Iván
Department of Internal Medicine, Division of Medicine, Hospital de Especialidades del Centro Médico Nacional “Siglo XXI”, Instituto Mexicano del Seguro Social, México City, 06720, México.

View Book :- https://stm.bookpi.org/HMMR-V11/article/view/889